| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2002 | Antibiotic usage in community-acquired infections in hospitals in Taiwan | Ho M.; Chang F.-Y.; Yin H.-C.; Ben R.-J.; LUAN-YIN CHANG ; Chen P.-Y.; Cheng S.-H.; Chen S.-T.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; JANN-TAY WANG | Journal of the Formosan Medical Association | 8 | 8 | |
| 2018 | Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan | Li C.-W.; Yang C.-J.; HSIN-YUN SUN ; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG ; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; CHIEN-CHING HUNG | PLoS ONE | 16 | 15 | |
| 2019 | Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study | Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN ; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; CHIEN-CHING HUNG ; Wang N.-C.; for the Taiwan HIV Study Group | Journal of Microbiology, Immunology and Infection | 7 | 6 | |
| 2010 | A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza | HSIANG-CHI KUNG ; KUO-CHIN HUANG ; Kao T.-M.; Lee Y.-C.; Chang F.-Y.; Wang N.-C.; Liu Y.-C.; Lee W.-S.; Liu H.-J.; Chen C.-I.; Chen C.-H.; LI-MIN HUANG ; SZU-MIN HSIEH | Vaccine | 18 | 15 | |
| 2001 | Correlates of antibiotic use in Taiwan hospitals | McDonald L.C.; Yu H.T.; Yin H.C.; Hsiung C.A.; CHIEN-CHING HUNG ; Ho M.; Gung C.; Gung S.-T.; Hsu M.-C.; Ben R.-J.; Lu D.C.T.; Lin H.-C.; Cheng S.-H.; Chen Y.-H.; Chen P.-Y.; Huang F.-L.; Chang F.-Y.; Wang N.-C.; Antibiotic Use Working Group | Infection Control and Hospital Epidemiology | 14 | 13 | |
| 2019 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials | Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG ; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; Sánchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Teófilo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serrão R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Castaño Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; González Cordón A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Liaño J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team | The Lancet | 210 | 205 | |
| 2020 | A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study | SUNG-CHING PAN ; Hsu W.-T.; Lee W.-S.; Wang N.-C.; Chen T.-J.; Liu M.-C.; Pai H.-C.; Hsu Y.-S.; Chang M.; SZU-MIN HSIEH | Vaccine | 7 | 6 | |
| 2021 | Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV | Lee Y.-L.; KUAN-YIN LIN ; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | International Journal of Antimicrobial Agents | 1 | 0 | |
| 2019 | Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors | Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN ; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG ; on behalf of the Taiwan HIV Study Group | Hepatology | 14 | 14 | |
| 2017 | Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan | Lee Y.-L.; KUAN-YIN LIN ; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG ; HSIN-YUN SUN ; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | PLoS ONE | 14 | 8 | |
| 2021 | Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan | Lin J.-J.; KUAN-YIN LIN ; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG ; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | Journal of Microbiology, Immunology and Infection | 7 | 8 | |
| 2008 | Inactive S298R disassembles the dodecameric l-aspartate 4-decarboxylase into dimers | Wang N.-C.; Ko T.-P.; Lee C.-Y.; CHIA-YIN LEE | Biochemical and Biophysical Research Communications | 8 | 5 | |
| 2018 | Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study | Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG ; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; CHIEN-CHING HUNG ; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YU-SHAN HUANG ; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. | Clinical Infectious Diseases | 15 | 15 | |
| 2006 | Molecular cloning of the aspartate 4-decarboxylase gene from Pseudomonas sp. ATCC 19121 and characterization of the bifunctional recombinant enzyme | Wang N.-C.; Lee C.-Y.; CHIA-YIN LEE | Applied Microbiology and Biotechnology | 18 | 17 | |
| 2017 | Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIVpositive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan | Wu P.-Y.; Cheng C.-Y.; Liu C.-E.; Lee Y.-C.; Yang C.-J.; Tsai M.-.S.; Cheng S.-H.; Lin S.-P.; Lin D.-Y.; Wang N.-C.; Lee Y.-.C.; HSIN-YUN SUN ; Tang H.-J.; CHIEN-CHING HUNG | PLoS ONE | 19 | 18 | |
| 2011 | Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia | Lu C.-L.; Lin Y.-H.; Wong W.-W.; Lin H.-H.; Ho M.-W.; Wang N.-C.; SZU-MIN HSIEH ; WANG-HUEI SHENG ; CHIEN-CHING HUNG ; Chen M.-Y. | Journal of Microbiology, Immunology and Infection | 14 | 10 | |
| 2021 | Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study | Liou B.-H.; HSIN-YUN SUN ; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG ; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG ; the Taiwan HIV Study Group | Infectious Diseases and Therapy | 2 | 2 | |
| 2014 | Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: A case-control study | Chan M.-C.; Chiu S.-K.; PO-REN HSUEH ; Wang N.-C.; Wang C.-C.; CHI-TAI FANG | PLoS ONE | 34 | 32 | |
| 2017 | Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial | UN-IN WU ; SZU-MIN HSIEH ; Lee W.-S.; Wang N.-C.; HSIANG-CHI KUNG ; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Vaccine | 23 | 22 | |
| 2021 | Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study | Huang, Sung-Hsi; Lee, Chun-Yuan; Tsai, Chin-Shiang; Tsai, Mao-Song; Liu, Chun-Eng; Hsu, Wei-Ting; Chen, Hong-An; WANG-DA LIU ; Yang, Chia-Jui; HSIN-YUN SUN ; Ko, Wen-Chien; Lu, Po-Liang; Lee, Yuan-Ti; CHIEN-CHING HUNG ; HSIN-YUN SUN ; YU-SHAN HUANG ; SUI-YUAN CHANG ; Taiwan HIV Study Group; Chen L.-Y.; Zhang J.-Y.; Chang H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG ; Wang N.-C.; Lin T.-Y.; KUAN-YIN LIN ; Yang C.-J.; Chen H.-A.; Tsai M.-S.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YI-CHIA HUANG ; Huang S.-H.; Lee Y.-T.; Lin J.-J.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Chen G.-J.; Lin C.-Y.; Hung T.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Tsai C.-S.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Lee C.-Y.; Chen Y.-H.; Lee C.-H.; Tsai H.-C.; Che T.-C.; Taiwan HIV Study Group | Infectious diseases and therapy | 0 | 0 | |
